Lower extremity lymphoedema is common after many cancers. Nevertheless, epidemiological estimates of the prevalence of lower extremity lymphoedema vary widely. A recent study, however, clarified the rates in women with colorectal, endometrial and ovarian malignancies: about one third self-reported lower extremity lymphoedema. The study also confirmed that lower extremity lymphoedema can markedly undermine physical functioning. Some patients, however, seem to be at especially high-risk of developing lower extremity lymphoedema, such as those who undergo extensive lymphadenectomy. Moreover, until recently, few clinical trials assessed treatment benefits from the patient's perspective. A recent study explored the goals and benefits that matter most to patients, which may help healthcare professionals individualise management.